Literature DB >> 19738920

Polar body biopsy in the diagnosis of monogenic diseases: the birth of three healthy children.

Georg Griesinger1, Nana Bündgen, Diana Salmen, Eberhard Schwinger, Gabriele Gillessen-Kaesbach, Klaus Diedrich.   

Abstract

BACKGROUND: For prospective parents at risk of transmitting a monogenic disease, polar body analysis is an option for pre-conception genetic diagnosis. In Germany, polar body analysis is currently performed in only two centers (Lübeck and Regensburg).
METHODS: The authors present a clinical series of 9 couples at risk for the transmission of a monogenic disease who underwent in vitro fertilization with polar body analysis.
RESULTS: Nine couples have undergone in vitro fertilization with polar body analysis at the center in Lübeck since 2004. Three healthy children were born after polar body analysis for mucopolysaccharidosis type I, incontinentia pigmenti, and cystic fibrosis. The decision to undergo in vitro fertilization with polar body analysis is not easy for prospective parents to take, even though it often follows years of emotional suffering. Treatment with the methods of reproductive medicine in general, and with polar body analysis in particular, can cause considerable physical and emotional stress.
CONCLUSIONS: For prospective parents in Germany at risk of transmitting a monogenic disease, polar body-based preimplantation diagnosis is an alternative to prenatal diagnosis and possible termination of pregnancy. The live birth rate per treatment cycle in this clinical series was 30%, which can be considered satisfactory. Nonetheless, most of the couples who did not achieve pregnancy after a first treatment cycle dropped out of treatment prematurely and did not go on to a second cycle.

Entities:  

Keywords:  in vitro fertilization; infertility; polar body; preimplantation diagnosis; prenatal diagnosis

Mesh:

Year:  2009        PMID: 19738920      PMCID: PMC2737433          DOI: 10.3238/arztebl.2009.0533

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  16 in total

1.  ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006.

Authors:  V Goossens; G Harton; C Moutou; P N Scriven; J Traeger-Synodinos; K Sermon; J C Harper
Journal:  Hum Reprod       Date:  2008-07-18       Impact factor: 6.918

2.  Polar body diagnosis - a step in the right direction?

Authors:  Katrin van der Ven; Markus Montag; Hans van der Ven
Journal:  Dtsch Arztebl Int       Date:  2008-03-14       Impact factor: 5.594

3.  Biopsy of human preimplantation embryos and sexing by DNA amplification.

Authors:  A H Handyside; J K Pattinson; R J Penketh; J D Delhanty; R M Winston; E G Tuddenham
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 4.  Male cases of incontinentia pigmenti: case report and review.

Authors:  A E Scheuerle
Journal:  Am J Med Genet       Date:  1998-05-18

Review 5.  Modern management of spinal muscular atrophy.

Authors:  Susan T Iannaccone
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

Review 6.  Molecular mechanisms of spinal muscular atrophy.

Authors:  Charlotte J Sumner
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

7.  Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

Authors:  J Pearn
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

8.  Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.

Authors:  H S Scott; T Litjens; P V Nelson; P R Thompson; D A Brooks; J J Hopwood; C P Morris
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

9.  Therapy resistant neonatal seizures, linear vesicular rash, and unusually early neuroradiological changes: incontinentia pigmenti: a case report, literature review and insight into pathogenesis.

Authors:  Gregor W Kaczala; Manuela A Messer; Ken J Poskitt; Juliette S Prendiville; Jane Gardiner; Christof Senger
Journal:  Eur J Pediatr       Date:  2007-10-16       Impact factor: 3.183

10.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

Authors:  A Smahi; G Courtois; P Vabres; S Yamaoka; S Heuertz; A Munnich; A Israël; N S Heiss; S M Klauck; P Kioschis; S Wiemann; A Poustka; T Esposito; T Bardaro; F Gianfrancesco; A Ciccodicola; M D'Urso; H Woffendin; T Jakins; D Donnai; H Stewart; S J Kenwrick; S Aradhya; T Yamagata; M Levy; R A Lewis; D L Nelson
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

View more
  1 in total

1.  A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti.

Authors:  Myung Joo Kim; Sang Woo Lyu; Hyun Ha Seok; Ji Eun Park; Sung Han Shim; Tae Ki Yoon
Journal:  Clin Exp Reprod Med       Date:  2014-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.